Claudine
Claudine Astorri, Pittsburgh, PA US
Patent application number | Description | Published |
---|---|---|
20100004933 | VOICE DIRECTED SYSTEM AND METHOD CONFIGURED FOR ASSURED MESSAGING TO MULTIPLE RECIPIENTS - A communications system transmits messages via a wireless network to multiple users nearly simultaneously in real-time. Each user has a terminal that receives a message and plays the message for the user. The terminal may also wait for the user to verbally acknowledge the arrival of the message before continuing with its normally executing application. The sender of the message may track, for each intended recipient, the delivery of the message, the accessing of the message by the user, and the acknowledgement by the user that the message was understood. | 01-07-2010 |
20110287751 | VOICE DIRECTED SYSTEM AND METHOD CONFIGURED FOR ASSURED MESSAGING TO MULTIPLE RECIPIENTS - A communications system transmits messages via a wireless network to multiple users nearly simultaneously in real-time. Each user has a terminal that receives a message and plays the message for the user. The terminal may also wait for the user to verbally acknowledge the arrival of the message before continuing with its normally executing application. The sender of the message may track, for each intended recipient, the delivery of the message, the accessing of the message by the user, and the acknowledgement by the user that the message was understood. | 11-24-2011 |
Claudine Blin-Wakkach, Nice FR
Patent application number | Description | Published |
---|---|---|
20090148452 | Composition for treating cancer adapted for intra-tumoral administration and uses thereof - A composition is adapted for intra-tumoral administration of a subject suffering from cancer, whereby administration of the composition to the subject induces IMC differentiation by neutralizing a factor implicated in a DC differentiation defect. | 06-11-2009 |
Claudine Bloyaert, Waterloo BE
Patent application number | Description | Published |
---|---|---|
20110257306 | Composition based on a vinyl halide polymer - Composition comprising at least one vinyl halide polymer and 0.1 to 5% by weight, relative to the weight of the vinyl halide polymer, of at least one polymer of at least one acrylic ester obtained by polymerization in solution in a liquid medium comprising at least one chain transfer agent chosen among the C | 10-20-2011 |
20140094543 | Manufacture and use of a composite material comprising fibres and at least one vinyl chloride polymer - Process for manufacturing a composite material comprising fibres and at least one vinyl chloride polymer comprising the immersion of the fibres in a hydrosol of said polymer in order to obtain fibres coated with said hydrosol followed by the drying and gelling of said hydrosol coated on the fibres. Composite material and use thereof for forming articles or for manufacturing reinforcing objects. Profiles reinforced by this composite material. | 04-03-2014 |
20150218361 | Composition based on a vinyl halide polymer - Composition comprising at least one vinyl halide polymer and 0.1 to 5% by weight, relative to the weight of the vinyl halide polymer, of at least one polymer of at least one acrylic ester obtained by polymerization in solution in a liquid medium comprising at least one chain transfer agent chosen among the C | 08-06-2015 |
Claudine Bruck, Rixensart BE
Patent application number | Description | Published |
---|---|---|
20090053291 | FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS - The invention provides (a) an HIV Tat protein or derivative thereof linked to either (i) a fusion partner or (ii) an HIV Nef protein or derivative thereof; or (b) an HIV Nef protein or derivative thereof linked to either (i) a fusion partner or (ii) an HIV Tat protein or derivative thereof; or (c) an HIV Nef protein or derivative thereof linked to an HIV Tat protein or derivative thereof and a fusion partner. The invention further provides for a nucleic acid encoding such a protein and a host cell, such as | 02-26-2009 |
20100215681 | FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS - The invention provides (a) an HIV Tat protein or derivative thereof linked to either (i) a fusion partner or (ii) an HIV Nef protein or derivative thereof; or (b) an HIV Nef protein or derivative thereof linked to either (i) a fusion partner or (ii) an HIV Tat protein or derivative thereof; or (c) an HIV Nef protein or derivative thereof linked to an HIV Tat protein or derivative thereof and a fusion partner. The invention further provides for a nucleic acid encoding such a protein and a host cell, such as | 08-26-2010 |
Claudine Buess-Herman, Overijse BE
Patent application number | Description | Published |
---|---|---|
20100139691 | METHOD FOR THE PLASMA CLEANING OF THE SURFACE OF A MATERIAL COATED WITH AN ORGANIC SUBSTANCE AND THE INSTALLATION FOR CARRYING OUT SAID METHOD - The invention relates to a method of cleaning the surface of a material that is coated with an organic substance. The inventive method is characterized in that it comprises the following steps, consisting in: introducing the material into a treatment chamber, having a pressure of between 10 mbar and 1 bar therein, which is supplied with a gas stream containing at least 90 volume percent of oxygen; and generating a plasma by passing an electric discharge between the surface of the material and a dielectric-covered electrode in order to break down the organic substance under the action of the free radicals O thus produces. The invention also relates to an installation that is used to carry out said method. | 06-10-2010 |
20100139864 | METHOD FOR THE PLASMA CLEANING OF THE SURFACE OF A MATERIAL COATED WITH AN ORGANIC SUBSTANCE AND THE INSTALLATION FOR CARRYING OUT SAID METHOD - The invention relates to a method of cleaning the surface of a material that is coated with an organic substance. The inventive method is characterized in that it comprises the following steps, consisting in: introducing the material into a treatment chamber, having a pressure of between 10 mbar and 1 bar therein, which is supplied with a gas stream containing at least 90 volume percent of oxygen; and generating a plasma by passing an electric discharge between the surface of the material and a dielectric-covered electrode in order to break down the organic substance under the action of the free radicals O thus produces. The invention also relates to an installation that is used to carry out said method. | 06-10-2010 |
Claudine Civiale, Lavinaio IT
Patent application number | Description | Published |
---|---|---|
20090221545 | Ophthalmic Pharmaceutical Composition Containing Amphiphilic Polyaspartamide Copolymers - The present invention relates in general to the use of amphiphilic graft-type copolymers of polyaspartamide for the ophthalmic administration of drugs, such as for example steroidal and non-steroidal anti-inflammatory agents, antimicrobial agents such as aminoglycosides, macrolides, cephalosporin, tetracycline, quinolones, penicillin, beta-lactams, anti-glaucoma agents such as prostaglandins, alpha- and beta-blockers, inhibitors of carbonic anhydrase, cannabinoids, antiviral agents, diagnostic agents, anti-angiogenic agents, antioxidants. | 09-03-2009 |
Claudine Civiale, Acicatena IT
Patent application number | Description | Published |
---|---|---|
20110117189 | OPHTHALMIC COMPOSITIONS FOR TREATING PATHOLOGIES OF THE POSTERIOR SEGMENT OF THE EYE - New compositions for ophthalmic use for the prevention and therapy of pathologies of the posterior segment of the eye. These compositions utilize xanthan gum as an active principle carrier, and can be advantageously administered as liquid-gel eye drops on the surface of the eye and optionally used in combination with other therapies for the treatment of the same pathologies. | 05-19-2011 |
Claudine Delavy, London GB
Patent application number | Description | Published |
---|---|---|
20090115588 | EMERGENCY INTERVENTION SYSTEM AND APPROPRIATE METHOD FOR AUTOMATICALLY REDRESSING MALFUNCTIONS IN MEANS OF TRANSPORT - The invention proposes an emergency intervention system and a method for automatically redressing malfunctions in means of transport ( | 05-07-2009 |
Claudine De Sa Botelho Pinto, Curitiba-Parana BR
Patent application number | Description | Published |
---|---|---|
20100173047 | FOOD PACKAGE HAVING WRAPPED STACK OF FOOD PRODUCTS AND METHOD FOR PACKAGING - A food package and method for forming the same are provided, where the food package includes an outer wrapper surrounding a stack of food products and a pair of end backers, one at each end of the stack, are enclosed within the wrapper. The end backers or sealing backers each provide a backing or sealing surface for use in forming the end seals in the outer wrapper. Pressure can be applied against the backers during formation of the end seals. | 07-08-2010 |
20100310731 | METHOD AND APPARATUS TO WRAP A PLASTIC CONTAINER - An apparatus comprises a closed container formed of substantially rigid plastic, and a wrapper that is loosely disposed fully about the closed container. This wrapper may also have twist ties on opposing ends thereof. This apparatus may be used to provide packaging for a retail commodity. | 12-09-2010 |
Claudine De Sa Botelho Pinto, Santo Inacio BR
Patent application number | Description | Published |
---|---|---|
20100239721 | METHOD AND APPARATUS TO FACILITATE ENCAPSULATING AN EDIBLE SUBSTANCE - An apparatus is provided comprising an edible substance, a discrete sheet of flexible film, and an adhesive disposed on the flexible film in a pattern that surrounds an adhesive-free space that is sized to accommodate the edible substance. The adhesive preferably does not extend to at least one edge of the flexible film. Portions of the adhesive contact other portions of the adhesive such that the discrete sheet encapsulates the edible substance, and the discrete sheet is twisted in at least one area that includes the adhesive. | 09-23-2010 |
Claudine De Sá Botelho Pinto, Santo Inacio-Curitiba-Parana BR
Patent application number | Description | Published |
---|---|---|
20100196550 | Chocolate Confectionery Product With Superior Stability - Packaged chocolate confectionery products and method described herein provide substantially increased stability and shelf life. The packaging and method is particularly suited for extending the stability and shelf life of chocolate confectionery items comprising a first chocolate component and a second component comprising a food ingredient, such as nuts, wafers, biscuits, liqueurs, fruit fillings, fat-containing fillings, and combinations thereof. The package comprises a rigid thermoformed or injection formed container having at least one recessed area surrounded by a peripheral sealing rim. A membrane, which is substantially impervious to oxygen and moisture, is sealed to the peripheral sealing rim. The container is formed of a thermoplastic laminate including at least one oxygen barrier layer, which is positioned between at least one inner and at least one outer polymer layer. The barrier layer is substantially impervious to oxygen and is effective to enhance the moisture barrier properties of the container. | 08-05-2010 |
Claudine De Sá Botelho Pinto, Santo Inacio-Curitiba-Parana BR
Patent application number | Description | Published |
---|---|---|
20100196550 | Chocolate Confectionery Product With Superior Stability - Packaged chocolate confectionery products and method described herein provide substantially increased stability and shelf life. The packaging and method is particularly suited for extending the stability and shelf life of chocolate confectionery items comprising a first chocolate component and a second component comprising a food ingredient, such as nuts, wafers, biscuits, liqueurs, fruit fillings, fat-containing fillings, and combinations thereof. The package comprises a rigid thermoformed or injection formed container having at least one recessed area surrounded by a peripheral sealing rim. A membrane, which is substantially impervious to oxygen and moisture, is sealed to the peripheral sealing rim. The container is formed of a thermoplastic laminate including at least one oxygen barrier layer, which is positioned between at least one inner and at least one outer polymer layer. The barrier layer is substantially impervious to oxygen and is effective to enhance the moisture barrier properties of the container. | 08-05-2010 |
Claudine Friederici, Mamer LU
Patent application number | Description | Published |
---|---|---|
20130206875 | DRY GRANULATION OF METALLURGICAL SLAG - A process for dry granulation of hot liquid slag wherein the hot liquid slag is mixed with solid metallic particles so as to form a solidified, vitrified slag cake mixed with the metallic particles, the slag cake is crushed so as to form hot slag particles and heated solid particles, said particles are cooled and said solid metallic particles are recycled. | 08-15-2013 |
20130292878 | GRANULATION OF METALLURGICAL SLAG - A process for granulation of hot liquid slag where the hot liquid slag is mixed with solid metallic particles so as to form a solidified, vitrified slag cake mixed with said metallic particles and said slag cake is discharged in a water bath. | 11-07-2013 |
Claudine Gardaz, Rumilly FR
Patent application number | Description | Published |
---|---|---|
20080237241 | Cookware Exhibiting an Improved Scratch Resistance - A culinary article formed from a metal support and a non-stick coating deposited at least on the surface of the metal support constituting the interior of the culinary article, where the non-stick coating includes at least two coats based on fluorocarbonated resin, with one of these two coats, which covers at least the worked surface of the interior of the culinary article, being a discontinuous coat forming patterns. Any cross section of the culinary article, at least at its worked surface, has regular interruptions in the plane of the discontinuous coat, and each pattern has an area of at least 1 mm | 10-02-2008 |
Claudine Gleyzal, Lyon FR
Patent application number | Description | Published |
---|---|---|
20100040710 | Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers. - The invention relates to the stimulation of the synthesis and of the activity of an isoform of lysyl oxidase, and more particularly of the LOXL (lysyl oxidase-like) isoform. | 02-18-2010 |
20110014175 | STIMULATION OF THE SYNTHESIS OF THE ACTIVITY OF AN ISOFORM OF LYSL OXIDASE-LIKE LOXL FOR STIMULATING THE FORMATION OF ELASTIC FIBRES - The invention relates to the stimulation of the synthesis and of the activity of an isoform of lysyl oxidase, and more particularly of the LOXL (lysyl oxidase-like) isoform. | 01-20-2011 |
20110223264 | Substancefor Restoring Normal Co-expression and Interaction Between the LOX and NRAGE Proteins - The invention relates to a substance for restoring normal co-expression and interaction between the LOX and NRAGE proteins. | 09-15-2011 |
20120225141 | SUBSTANCE FOR RESTORING NORMAL CO-EXPRESSION AND INTERACTION BETWEEN THE LOX AND NRAGE PROTEINS - The disclosed substance restores normal co-expression and interaction between the LOX and NRAGE proteins. Particularly, an effective amount of the substance that modulates the expression and/or activity of LOX of SEQ ID NO: 1 and/or that modulates the expression and/or activity of NRAGE of SEQ ID NO: 2, may be used for the manufacture of a composition for modulating the interaction between the LOX and NRAGE proteins to regulate the balance between the cellular phenomena of proliferation, differentiation and apoptosis, particularly in cases where the balance between these phenomena is disturbed, and especially in cases where the interaction between LOX and NRAGE is absent or altered. The invention makes it possible especially to treat and/or prevent skin ageing, lichen planus, graft-versus-host reaction (GVH), eczema, psoriasis and a cancer, particularly an epithelial cancer and more particularly a cutaneous epithelial cancer of basocellular or spinocellular type. | 09-06-2012 |
20130011902 | STIMULATION OF THE SYNTHESIS OF THE ACTIVITY OF AN ISOFORM OF LYSYL OXIDASE-LIKE LOXL FOR STIMULATING THE FORMATION OF ELASTIC FIBERS - The invention relates to the stimulation of the synthesis and of the activity of an isoform of lysyl oxidase, and more particularly of the LOXL (lysyl oxidase-like) isoform. The invention relates notably to a method of identifying an active principle which stimulates the formation of elastic fibers. The aim of the invention is mainly to provide such a method of identification so as to provide compositions which enable stimulating the formation of elastic fibers. | 01-10-2013 |
20160095815 | SUBSTANCE FOR RESTORING NORMAL CO-EXPRESSION AND INTERACTION BETWEEN THE LOX AND NRAGE PROTEINS - The invention relates to the use of a substance for restoring normal co-expression and interaction between the LOX and NRAGE proteins. The invention relates in particular to the use of an effective amount of at least one substance that modulates the expression and/or activity of the LOX of SEQ ID NO: 1 and/or that modulates the expression and/or activity of the NRAGE of SEQ ID NO: 2 for modulating the interaction between the LOX and NRAGE proteins to regulate the balance between the cellular proliferation, differentiation and apoptosis, particularly in cases where the balance between these phenomena is disturbed, and especially in cases where the interaction between LOX and NRAGE is absent or altered. The invention makes it possible to treat skin ageing, lichen planus, graft-versus-host reaction (GVH), eczema, psoriasis and a cancer, particularly an epithelial cancer and more particularly a cutaneous epithelial cancer of basocellular or spinocellular type. | 04-07-2016 |
Claudine Guerin-Marchand, Paris FR
Patent application number | Description | Published |
---|---|---|
20080213795 | DNA sequences encoding peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes - The invention discloses isolated DNA sequences encoded by polypeptides characterized by the presence in their structure of one or more sequences bearing all or part of the one or more T epitopes, and possibly other epitopes, particularly B epitopes, characteristic of proteins resulting from the infectious activity of | 09-04-2008 |
Claudine Habak, Saint-Laurent CA
Patent application number | Description | Published |
---|---|---|
20150230744 | METHOD AND SYSTEM FOR ASSESSING A STIMULUS PROPERTY PERCEIVED BY A SUBJECT - A method for assessing a subject perception of a stimulus property, comprising: applying to a subject at least a first sensory stimulus having a first value for the stimulus property and a second sensory stimulus having a second value for the stimulus property different from the first value; requesting the subject to identify a characteristic of the first and second sensory stimuli during the application thereof, the characteristic being unrelated to the stimulus property to be assessed, thereby focusing an attention of the subject on a decision making task; measuring an activity of at least one brain region of the subject during the application of the first and second sensorial stimuli and the identification of the characteristic thereof, thereby obtaining a brain activity measurement; and determining a difference of stimulus property perceived by the subject between the first and second sensory stimuli from the brain activity measurement. | 08-20-2015 |
20150238083 | METHOD AND SYSTEM FOR OPTICALLY INVESTIGATING A TISSUE OF A SUBJECT - There is described a probe device for optically investigating a tissue of a subject, comprising: a first probe element, a second probe element, and a third probe element each to be positioned at a respective vertex of a triangle for sensing the tissue, the first probe element each comprising a first light source for emitting light having a first wavelength, the second probe element each comprising a second light source for emitting light having a second wavelength and a first photodetector for detecting light having the first wavelength and scattered by the tissue, and the third probe element comprising a second photodetector for detecting light having the first and second wavelengths and scattered by the tissue. | 08-27-2015 |
Claudine Kieda, Orleans FR
Patent application number | Description | Published |
---|---|---|
20120003327 | METHOD OF REDUCING MULTI-DRUG RESISTANCE USING INOSITOL TRIPYROPHOSPHATE - Inositol trisphosphate (ITPP) causes normalization of tumor vasculature and is a particularly effective cancer therapy when a second chemotherapeutic agent is administered following partial vascularization. ITPP also treats, alone or in combination, multi-drug resistant cancers. ITPP can also be used to reduce the amount of a second chemotherapeutic drug required for anticancer activity. In addition, ITPP enhances immune response and treats hyperproliferative disorders. | 01-05-2012 |
20130017547 | ORGAN-SPECIFIC FELINE ENDOTHELIAL CELLS AND USES THEREOFAANM Kieda; ClaudineAACI OrleansAACO FRAAGP Kieda; Claudine Orleans FRAANM Paprocka; MariaAACI WroclawAACO PLAAGP Paprocka; Maria Wroclaw PLAANM Mitterand; MicheleAACI ArdonAACO FRAAGP Mitterand; Michele Ardon FRAANM Lamerant-Fayel; NathalieAACI OlivetAACO FRAAGP Lamerant-Fayel; Nathalie Olivet FRAANM Boulouis; Henri-JeanAACI La Varenne Saint HilaireAACO FRAAGP Boulouis; Henri-Jean La Varenne Saint Hilaire FRAANM Haddad; NadiaAACI Saint-MauriceAACO FRAAGP Haddad; Nadia Saint-Maurice FRAANM Monteil; MartineAACI Villeneuve-Saint-GeorgesAACO FRAAGP Monteil; Martine Villeneuve-Saint-Georges FR - The present invention relates to isolated organ-specific feline endothelial cells. Specifically, the present invention relates to established organ-specific feline endothelial cells. The present invention also relates to organ-specific feline endothelial cells derived from micro- and macro-vascularisation. The present invention also relates to methods for screening molecules, for studying pathologies and for producing pathogens using same. | 01-17-2013 |
20130040315 | HUMAN AND MURINE STEM-CELL LINES: MODELS OF ENDOTHELIAL CELL PRECURSORS - The present invention relates to isolated human cells that are precursors of endothelial cells other than embryonic stem cells, to isolated murine cells that are precursors of endothelial cells, and to methods using same, In particular, the present invention relates to established cell lines of isolated human cells that are precursors of endothelial cells other than embryonic stem cells and established cell lines of isolated murine cells that are precursors of endothelial cells. The present invention can be used in particular in the medical and/or veterinary fields, in particular in the field of therapeutics and/or in the field of studies of cellular mechanisms. | 02-14-2013 |
20140199261 | METHOD OF REDUCING MULTI-DRUG RESISTANCE USING INOSITOL TRIPYROPHOSPHATE - Inositol trisphosphate (ITPP) causes normalization of tumor vasculature and is a particularly effective cancer therapy when a second chemotherapeutic agent is administered following partial vascularization. ITPP also treats, alone or in combination, multi-drug resistant cancers. ITPP can also be used to reduce the amount of a second chemotherapeutic drug required for anticancer activity. In addition, ITPP enhances immune response and treats hyperproliferative disorders. | 07-17-2014 |
Claudine Le Mercier, Ploubezre FR
Patent application number | Description | Published |
---|---|---|
20100037298 | Method and System for Protecting a Service Access Link - A method and a system for securing access to data stored in a remote content server ( | 02-11-2010 |
Claudine Madoulet, Reims FR
Patent application number | Description | Published |
---|---|---|
20110064795 | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers - The invention relates to an immunogenic composition which comprises, firstly, a carrier and, secondly, as antigenic structure, conjugates comprising all or part of the amino acid sequences of at least one peptide derived from an extracellular loop of the P-170 protein, each peptide being combined with several molecules of fatty acid containing a carbon chain of between C12 and C24 so as to allow, under suitable administration conditions, the induction of anti-P-170 antibodies. | 03-17-2011 |
Claudine Mayer, Strasbourg FR
Patent application number | Description | Published |
---|---|---|
20090311714 | Methods for the Screening of Antibacterial Substances - The present invention concerns a method for the screening of antibacterial substances comprising a step of determining the ability of a candidate substance to inhibit the activity of a purified enzyme selected from the group consisting of: (i) a D-aspartate ligase comprising a polypeptide having an amino acid sequence possessing at least 50% amino acid identity with an amino acid sequence selected from the group consisting of SEQ ID No 1 to SEQ ID No 10, or a biologically active fragment thereof; and (ii) a L,D-transpeptidase comprising a polypeptide having an amino acid sequence possessing at least 50% amino acid identity with the amino acid sequence of SEQ ID No 11, or a biologically active fragment thereof. | 12-17-2009 |
20150094229 | METHODS FOR THE SCREENING OF ANTIBACTERIAL SUBSTANCES - The present invention concerns a method for the screening of antibacterial substances comprising a step of determining the ability of a candidate substance to inhibit the activity of a purified enzyme selected from the group consisting of: (i) a D-aspartate ligase comprising a polypeptide having an amino acid sequence possessing at least 50% amino acid identity with an amino acid sequence selected from the group consisting of SEQ ID No 1 to SEQ ID No 10, or a biologically active fragment thereof; and (ii) a L,D-transpeptidase comprising a polypeptide having an amino acid sequence possessing at least 50% amino acid identity with the amino acid sequence of SEQ ID No 11, or a biologically active fragment thereof. | 04-02-2015 |
Claudine Mazurier, Villeneuve-D'Ascq FR
Patent application number | Description | Published |
---|---|---|
20080318841 | Method For Preparing a Factor H Concentrate and the Use Thereof in the Form of a Drug - The invention relates to the use of a factor H for producing a drug for treating Uremic Haemolytic Syndrome (UHS), to a method for purifying the factor H from a frozen fresh plasma and to a factor H concentrate obtainable by said method. | 12-25-2008 |
20100009396 | METHOD FOR MEASURING THE CONCENTRATION OF ACTIVATED FACTOR VII (FVIIA) IN A SAMPLE - The present application concerns a method for the in vitro or ex-vivo measurement of the FVIIa concentration of a sample, comprising the steps consisting of: | 01-14-2010 |
Claudine Miraval, Bethune FR
Patent application number | Description | Published |
---|---|---|
20160115562 | FERRITIC STAINLESS STEEL SHEET, METHOD FOR THE PRODUCTION THEREOF, AND USE OF THE SAME, ESPECIALLY IN EXHAUST LINES - A ferritic stainless steel sheet of a composition, expressed in weight percentages: trace amounts≦C≦0.03%; 0.2%≦Mn≦1%; 0.2%≦Si≦1%; trace amounts≦S≦0.01%; trace amounts≦P≦0.04%; 15%≦Cr≦22%; trace amounts≦Ni≦0.5%; trace amounts≦Mo≦2%; trace amounts≦Cu≦0.5%; 0.160%≦Ti≦1%; 0.02%≦Al≦1%; 0.2%≦Nb≦1%; trace amounts≦V≦0.2%; 0.009%≦N≦0.03%; trace amounts≦Co≦0.2%; trace amounts≦Sn≦0.05%; rare earths (REE)≦0.1%; trace amounts≦Zr≦0.01%; the remainder of the composition consisting of iron and of inevitable impurities resulting from the elaboration; the Al and rare earth (REE) contents satisfying the relationship: Al+30×REE≧0.15%; the Nb, C, N and Ti contents in % satisfy the relationship: 1/[Nb+(7/4)×Ti−7×(C+N)]≦3; said metal sheet having an entirely recrystallized structure and an average ferritic grain size comprised between 25 and 65 μm. | 04-28-2016 |
Claudine Rangheard, Lyon FR
Patent application number | Description | Published |
---|---|---|
20110009581 | METHOD OF PREPARING A CATALYTIC COMPOSITION FOR DIMERIZATION, CO-DIMERIZATION AND OLIGOMERIZATION OF OLEFINS - The present invention describes a method of preparing a catalytic composition used for oligomerization, co-dimerization or polymerization of olefins, wherein the compound obtained upon contacting at least one iron compound with at least one nitrogen-containing compound is subjected to an oxidation stage prior to being mixed with an activating agent and optionally with a solvent. | 01-13-2011 |
20110009635 | NOVEL NITROGEN-CONTAINING ORGANIC COMPOUNDS USABLE AS CATALYTIC COMPOSITION PRECURSORS - The present invention describes novel nitrogen-containing organic compounds obtained by reacting a compound X of substituted pyridine type comprising at least one ketone function with a compound Y belonging to the aminoquinoleine family and derivatives thereof. Said organic compounds can be used as precursors in a catalytic composition. | 01-13-2011 |
20110263804 | PROCESS FOR THE PREPARATION OF A CATALYST COMPOSITION FOR DIMERIZATION, CODIMERIZATION AND OLIGOMERIZATION OF OLEFINS - This invention describes a process for the preparation of a catalytic composition that can be used for oligomerization, codimerization, or polymerization of olefins. This invention also describes the catalytic composition that can be obtained by said process for the preparation and its use for oligomerization, codimerization, or polymerization of olefins. | 10-27-2011 |
Claudine Tordjman, Holon IL
Patent application number | Description | Published |
---|---|---|
20160134444 | METHOD AND APPARATUS FOR CORRELATION CANCELLER FOR INTERFERENCE MITIGATION WITH ADAPTIVE DC OFFSET CANCELLATION - A method and apparatus for a method and apparatus for correlation canceller for interference mitigation with adaptive DC offset cancellation for a dual mode communication device includes detecting an active signal transmitting in one mode; configuring integrators associated with the adaptive correlation canceller into gain amplifiers; detecting DC offset utilizing the gain amplifiers and comparators; and configuring the integrators from the gain amplifiers back to integrators with the DC offset applied thereto. The active signal transmitting in one mode can be Long Term Evolution (LTE) which is adjacent to a signal in another mode. | 05-12-2016 |
Claudine Vermot-Desroches, Dardilly FR
Patent application number | Description | Published |
---|---|---|
20130183306 | ANTI-CD19 ANTIBODY HAVING ADCC FUNCTION WITH IMPROVED GLYCOSYLATION PROFILE - The present invention relates to an anti-CD19 antibody having a variant Fc region having some specific amino acid modifications relative to a wild-type Fc region which confer one or several useful effector functions. The present invention relates in particular to chimeric, humanized or full human anti-CD19 antibodies comprising such a variant Fc region. It relates advantageously to antibodies with an interesting and valuable glycosylation profile, especially a low fucose level and/or a high oligomannose level and low level of sialic acid, high ADCC function and no CDC. The present invention also relates to the use of these antibodies in the treatment, prevention or management of diseases or disorders, such as cancer, especially a B-cell malignancy and auto-immune disease. | 07-18-2013 |
20130217863 | Method to Improve Glycosylation Profile and to Induce Maximal Cytotoxicity for Antibody - The present invention relates to the production of recombinant glycoproteins or antibodies that have an improved glycosylation profile and effector functions such as ADCC and/or CDC. The present invention is in particular related to the production of glycoproteins or antibodies having a valuable glycosylation profile, especially a low fucose level and/or a high oligomannose level and/or presence of sialic acid to the glycans. | 08-22-2013 |
20130224190 | ANTI-CD19 ANTIBODY HAVING ADCC AND CDC FUNCTIONS AND IMPROVED GLYCOSYLATION PROFILE - The present invention relates to an anti-CD19 antibody having a variant Fc region having some specific amino acid modifications relative to a wild-type Fc region which confer one or several useful effector functions. The present invention relates in particular to chimeric, humanized or full human anti-CD19 antibodies comprising such a variant Fc region. It relates advantageously to antibodies with an interesting and valuable glycosylation profile, especially a low fucose level and/or a high oligomannose level and low level of sialylated glycoform. The present invention also relates to the use of these antibodies in the treatment, prevention or management of disease or disorder, such as cancer, especially a B-cell malignancy, and auto-immune disease. | 08-29-2013 |